{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T12:55:22Z","timestamp":1774875322847,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,1,24]],"date-time":"2012-01-24T00:00:00Z","timestamp":1327363200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Ophthal Inflamm Infect"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1007\/s12348-011-0058-2","type":"journal-article","created":{"date-parts":[[2012,1,22]],"date-time":"2012-01-22T23:47:03Z","timestamp":1327276023000},"page":"145-147","source":"Crossref","is-referenced-by-count":19,"title":["A case report of adalimumab-associated optic neuritis"],"prefix":"10.1186","volume":"2","author":[{"given":"Alice","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norman","family":"Saffra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,1,24]]},"reference":[{"key":"58_CR1","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jns.2006.01.012","volume":"244","author":"JH Chung","year":"2006","unstructured":"Chung JH, Van Stavern GP, Frohman LP, Turbin RE (2006) Adalimumab-associated optic neuritis. J Neurol Sci 244:133\u2013136","journal-title":"J Neurol Sci"},{"key":"58_CR2","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.1002\/1529-0131(200112)44:12<2862::AID-ART474>3.0.CO;2-W","volume":"44","author":"N Mohan","year":"2001","unstructured":"Mohan N, Edwards ET, Cupps TR et al (2001) Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides. Arthritis Rheum 44:2862\u20132869","journal-title":"Arthritis Rheum"},{"key":"58_CR3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/00054725-200401000-00004","volume":"10","author":"CW Thomas Jr","year":"2004","unstructured":"Thomas CW Jr, Weinshenker BG, Sandborn WJ (2004) Demyelination during anti-tumor necrosis factor alpha therapy with infliximab for Crohn\u2019s disease. Inflamm Bowel Dis 10:28\u201331","journal-title":"Inflamm Bowel Dis"},{"key":"58_CR4","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1002\/art.21814","volume":"54","author":"IS Shin","year":"2006","unstructured":"Shin IS, Baer AN, Kwon HJ et al (2006) Guillain\u2013Barre and Miller Fisher syndromes occurring with tumor necrosis factor alpha antagonist therapy. Arthritis Rheum 54:1429\u20131434","journal-title":"Arthritis Rheum"},{"key":"58_CR5","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1056\/NEJM199108153250704","volume":"325","author":"MK Sharief","year":"1991","unstructured":"Sharief MK, Hentges R (1991) Association between tumor necrosis factor alpha and disease progression in patients with multiple sclerosis. N Engl J Med 325:467\u2013472","journal-title":"N Engl J Med"},{"key":"58_CR6","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/ana.410300510","volume":"30","author":"K Selmaj","year":"1991","unstructured":"Selmaj K, Raine CS, Cross AH (1991) Anti-tumor necrosis factor therapy abrogates auto-immune demyelination. Ann Neurol 30:694\u2013700","journal-title":"Ann Neurol"},{"key":"58_CR7","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1084\/jem.172.4.1193","volume":"172","author":"H Ruddlen","year":"1990","unstructured":"Ruddlen H, Bergman CM, Mcgrath ML (1990) An antibody to lymphotoxin and tumor necrosis factor prevents transfer of xperimental allergic encephalomyelitis. J Exp Med 172:1193\u20131200","journal-title":"J Exp Med"},{"key":"58_CR8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/0165-5728(94)00139-F","volume":"56","author":"K Selmaj","year":"1995","unstructured":"Selmaj K, Papierz W, Glabinski A, Kohn OT (1995) Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble TNF receptor 1. J Neuroimmunol 56:135\u2013141","journal-title":"J Neuroimmunol"},{"key":"58_CR9","first-page":"11294","volume":"92","author":"L Probert","year":"1995","unstructured":"Probert L, Akassoglou K, Pasparakis M et al (1995) Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor-\u03b1. Neurobiology 92:11294\u201311298","journal-title":"Neurobiology"},{"key":"58_CR10","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1212\/WNL.47.6.1531","volume":"47","author":"BW Oosten van","year":"1996","unstructured":"van Oosten BW, Barkhof F, Truyen L et al (1996) Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology 47:1531\u20131534","journal-title":"Neurology"},{"key":"58_CR11","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1212\/WNL.53.3.457","volume":"53","author":"The Lenercept Multiple Sclerosis Study Group and the University of British Columbia\/MRI Analysis Group","year":"1999","unstructured":"The Lenercept Multiple Sclerosis Study Group and the University of British Columbia\/MRI Analysis Group (1999) TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. Neurology 53:457\u2013465","journal-title":"Neurology"},{"issue":"Suppl. 35","key":"58_CR12","first-page":"S134","volume":"22","author":"MD Magnano","year":"2004","unstructured":"Magnano MD, Robinson WH, Genovese MC (2004) Demyelination and inhibition of tumor necrosis factor (TNF). Clin Exp Rheumatol 22(suppl 35):S134\u2013S140","journal-title":"Clin Exp Rheumatol"},{"key":"58_CR13","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1136\/ard.2006.066787","volume":"66","author":"I Simsek","year":"2007","unstructured":"Simsek I, Erdem H, Pay S et al (2007) Optic neuritis occurring with anti-tumour necrosis factor \u03b1 therapy. Ann Rheum Dis 66:1255\u20131258","journal-title":"Ann Rheum Dis"}],"container-title":["Journal of Ophthalmic Inflammation and Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12348-011-0058-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12348-011-0058-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s12348-011-0058-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12348-011-0058-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,3]],"date-time":"2019-11-03T20:46:54Z","timestamp":1572814014000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12348-011-0058-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,24]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["58"],"URL":"https:\/\/doi.org\/10.1007\/s12348-011-0058-2","relation":{},"ISSN":["1869-5760"],"issn-type":[{"value":"1869-5760","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,24]]}}}